Cooperative Agreement 72061723CA00002

This $21,773,964 cooperative agreement awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to improve the quality, accessibility, affordability, and utilization of healthcare services in three urbanized districts in Uganda. The five-year activity, which commenced in November 2024, will focus on strengthening health system capacity, enhancing community involvement, and addressing service delivery...

This Cooperative Agreement award of $17,185,597.00 from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) aims to strengthen the technical capacity of the Ugandan Ministry of Health to standardize, harmonize, and provide oversight for a sustainable public health response to HIV/AIDS, TB, and related health efforts. The 5-year award, which begins on September 30, 2024, will support activities to build national health system capabilities,...

This $1,365,212 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program supports the development and testing of a peer-led dynamic choice HIV prevention intervention for women at elevated HIV risk in Uganda. The intervention aims to increase coverage of biomedical HIV prevention products such as oral pre-exposure prophylaxis (PrEP), the dapivirine vaginal ring (DVR), and long-acting cabotegravir (CAB-LA), as well as...

This $772,055 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports a 5-year research study entitled "Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living with HIV in Risk Environments." The primary objectives are to: 1) Determine the efficacy of the KISOBOKA intervention and its components (behavioral economics, motivational...

The National Institutes of Health (NIH) is providing a $205,235 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the University of North Carolina at Chapel Hill (UNC-CH) for the "KUPAMBANA" intervention study. The study aims to address intersectional HIV and poverty stigmas and strengthen economic capabilities among young people living with HIV in Zambia, in order to improve HIV care continuum and mental health outcomes. The two-phase project will first adapt...

The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242) totaling $547,321 to Makerere University College of Health Sciences in Uganda. The grant, entitled "SECONDARY DISTRIBUTION OF HIV SELF-TESTING BY FSW, PRE-EXPOSURE PROPHYLAXIS (PREP) STARTER PACKS AND BRIEF COUNSELING TO PROMOTE PREP INITIATION AND PERSISTENCE AMONG HIGH-RISK MEN IN UGANDA", aims to develop and pilot test an intervention that involves secondary distribution of HIV self-testing kits...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) totaling $381,487 aims to assess the implementation and early effects of long-acting injectable cabotegravir (CAB-LA) for HIV pre-exposure prophylaxis (PrEP) among adolescent girls and young women in Zambia. The "Scaling Comprehensive Access to Long-Acting for Equitable and Effective Use of PrEP (SCALE-UP)" study will use...

The National Institute of Mental Health (NIMH) awarded a $665,225 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Washington University in St. Louis to conduct the "SUUBI4PREP: Improving PREP Access and Adherence Among Adolescent Girls and Young Women in Uganda" research project. The goal of this 5-year study is to evaluate the impact of a multilevel intervention combining HIV risk reduction education, peer support, and economic empowerment components to increase...

This $1,566,226 Project Grant award from the National Institutes of Health (NIH) Office of the Director (CFDA 93.310 Trans-NIH Research Support) aims to evaluate the effectiveness and implementation of a couples-based shared decision-making intervention called CUPID. The intervention is designed to increase uptake, persistence, and adherence to biomedical HIV pre-exposure prophylaxis (PrEP) among women in Uganda. The study will refine the CUPID intervention for use in public health settings,...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $158,059 to the University of Alabama at Birmingham (UAB) to support a career mentoring program in patient-oriented HIV prevention research. The primary objectives are to: Provide mentorship in HIV prevention research to an estimated 15 investigators in the U.S. and abroad, with a focus on training mentors in effective...